Clinical Sessions for Recertification: Ambulatory Care Pharmacy (Cert # L209329)

ACPE Numbers:
Pre-sale Date: 11/18/2020
Content Release Date: 12/16/2020
Expiration Date: 12/14/2021
Activity Type: Application-based
CE Credits: 6.0 hours
Activity Fee: $150 (ASHP member); $250 (non-member)

Accreditation for Pharmacists

The American Society of Health-System Pharmacists and the American College of Clinical Pharmacy are accredited by the Accreditation Council for Pharmacy Education as a providers of continuing pharmacy education.

Target Audience

These recertification activities are intended for board-certified pharmacists seeking to update their knowledge and skills in:

  • Ambulatory Care
  • Geriatrics
  • Women’s Health
  • Secondary Stroke Prevention
  • Cognitive Impairment
  • Obesity

Activity Overview

The Clinical Sessions Package is intended for board-certified pharmacists in need of recertification credit and is designed based on the content outline developed by the Board of Pharmacy Specialties (BPS). Using a case-based approach, the activities provide high-level, interactive discussions on contemporary and emerging issues in ambulatory care pharmacy.

The Ambulatory Care Pharmacy Clinical Sessions Recertification Package consists of 4 activities (see table below) and provides up to 6.0 hours of continuing pharmacy education and/or recertification credit.  

These activities are part of the ASHP and ACCP professional development program for BCACP recertification approved by the BPS.  For pharmacists who maintain more than one certification, three of the activities are approved for multiple specialties (see table below).

Recertification Credit*

Board certified pharmacists are eligible to receive up to 6.0 hours of recertification credit for completing this package. To earn recertification credit, learners must review the activity content and successfully complete the online assessments by the deadline. Only completed assessments will be eligible for credit; no partial or incomplete assessments will be processed. You are allowed only one attempt to successfully complete this assessment.

Recertification credit is earned in the calendar year in which you pass the recertification assessment.

Learning Module

ACPE Number

Credit Hours


*Assessment Pass Point

The Weight of the World: Obesity Strategies and Controversies





An Unforgettable Session: The Pharmacist's Role in Mild Cognitive Impairment





Not so FAST – Engaging in SLOW Decision Making for Secondary Stroke Prevention





Managing Menopause: A "Hot" Topic






Learning Objectives

ACPE Number: 0217-9999-20-122-H01-P

Learning Objectives

At the conclusion of this application-based educational activity, participants should be able to do the following:

  • Develop patient-specific weight-loss goals.
  • Evaluate the risk-benefit of non-pharmacological, pharmacological, and surgical options for weight management.
  • Design an individualized treatment plan for weight management, incorporating evidence-based guidelines and primary literature.
  • Create a patient-specific counseling and monitoring plan, following a specific weight-loss intervention.

This activity is approved for Board Certified Ambulatory Care Pharmacist (BCACP) recertification credit.

ACPE Number: 0217-9999-20-121-H01-P

Learning Objectives

At the conclusion of this application-based educational activity, participants should be able to do the following:

  • Demonstrate appropriate use of a screening tool for cognitive impairment.
  • Determine potentially reversible causes of cognitive impairment, including potentially inappropriate medication use in this population.
  • Develop evidence-based and patient-centered treatment plans for older adults with mild cognitive impairment.

This activity is approved for Board Certified Ambulatory Care Pharmacist (BCACP) and Board Certified Geriatric Pharmacist (BCGP) recertification credit.

ACPE Number: 0204-9999-20-319-H01-P

Learning Objectives

At the conclusion of this application-based educational activity, participants should be able to do the following:

  • Evaluate literature that defines secondary stroke treatment goals, including prevention, to the care of older adults.
  • Identify clinical situations for secondary stroke prevention where life expectancy, functional status, patient preference or goals of care should override standard recommendations for screening/treatment.
  • Recommend secondary stroke prevention strategies for older adult patients with multiple conditions, including hypertension, dyslipidemia, atrial fibrillation, tobacco use disorder, diabetes, and hormone deficiency.

This activity is approved for Board Certified Ambulatory Care Pharmacist (BCACP) and Board Certified Geriatric Pharmacist (BCGP) recertification credit.

ACPE Number: 0204-9999-20-320-H01-P

Learning Objectives

At the conclusion of this application-based educational activity, participants should be able to do the following:

  • Describe the spectrum of symptoms present in a perimenopausal female.
  • Analyze the risk/benefit ratio of hormonal therapy for the management of perimenopausal symptoms.
  • Recommend therapeutic regimens for the management of perimenopausal vasomotor symptoms.
  • Select therapies for the management of postmenopausal osteoporosis taking into account guideline recommendations from the National Osteoporosis Foundation, The North American Menopause Society, and The Endocrine Society.

This activity is approved for Board Certified Ambulatory Care Pharmacist (BCACP) and Board Certified Geriatric Pharmacist (BCGP) recertification credit.

Planners, Presenters, and Reviewers

Full Faculty Bios

Geriatrics Clinical Pharmacy Specialist
Center for Geriatric Medicine
Cleveland Clinic
Cleveland, Ohio

Assistant Professor for Pharmacy Practice
Purdue University
West Lafayette, Indiana

Clinical Pharmacist in Diabetes Transition
Spartanburg Regional Healthcare System
Spartanburg, South Carolina

Assistant Professor, Department of Pharmacy Practice & Science               
University of Kentucky
Lexington, Kentucky

Clinical Pharmacy Specialist/CGM Program Coordinator
Department of Endocrinology, Diabetes & Metabolism
Cleveland Clinic Diabetes Center
Cleveland, Ohio

Associate Professor of Pharmacy Practice, Clinical Pharmacy Specialist
Chicago State University College of Pharmacy, Rush University Medical Center
Chicago, Illinois

Associate Professor of Pharmacy Practice and Clinical Pharmacist Specialist
Auburn University Harrison School of Pharmacy
Central Alabama, Virginia and Tuscaloosa, Virginia

Associate Professor
Virginia Commonwealth University School of Pharmacy
Falls Church, Virginia

Clinical Pharmacy Specialist - Neurology
Kaiser Permanente
Denver, Colorado

Clinical Pharmacy Specialist
Pharmacy Department
Kaiser Permanente Colorado
Denver, Colorado

Associate Professor of Pharmacy Practice
Mylan School of Pharmacy Clinical, Social, and Administrative Sciences
Duquesne University
Pittsburgh, Pennsylvania
Ambulatory Care Pharmacy Preparatory Review and Recertification Course

Holly L. Byrnes, Pharm D., BCPS
Susan R. Dombrowski, M.S., R.Ph.
Kristi Hofer, Pharm.D.
Dana Carroll, Pharm.D., BCPS, CDE, BCGP
Nicholas Leon, Pharm.D., BCPS, BCACP, FCPP
Amie Blaszczyk, Pharm.D., BCGP, BCPS, FASCP
Michelle Hilaire Pharm.D., BCACP, BCPS, CDE, FCCP

Apryl Anderson, Pharm.D., BCACP
Richard Avalos, Pharm.D., BCACP
Elisa Baddour, Pharm.D., BCACP
Ramadas Balasubramanian, Pharm.D., Ph.D., BCGP, BCACP, FASCP
Shaneka Baylor, Pharm.D., BCGP, BCACP, CDCES
Kamal Bhakta, Pharm.D., BCACP, R.Ph., M.B.A.
Emily Brandl, Pharm.D., BCGP
Bryan Brubaker, Pharm.D., BCACP, TTS
Madeline Burke, Pharm.D., BCGP
Tina Caliendo, Pharm.D., BCGP, BCACP
Timothy Carbone, Pharm.D., BCGP, M.B.A.
Abigail Case, Pharm.D., BCACP
David Choi, Pharm.D., BCACP
Stacey Dalton, Pharm.D., BCACP, PhC
Emily Ellsworth, Pharm.D., BCGP
Frank Fanizza, Pharm.D., BCACP
Susan Fedler, Pharm.D., BCACP
Bethany Franz, Pharm.D., BCACP
Kisha Gant, Pharm.D., BCACP, BCGP, BCPS
Lacey Garrett, Pharm.D., BCACP
Kathy Grams, B.S.Pharm., Pharm.D., BCGP
Justinne Guyton, Pharm.D., BCACP
Irene Hanna, BCACP
Morgan Harper, Pharm.D., BCACP
Rhenda Harris, Pharm.D., M.B.A., BCACP
Klara Janis, Pharm.D., BCACP, BCGP, CDCES
Muhammad Kanakri, Pharm.D., CPH., BCACP
Rebecca Kavanagh, Pharm.D., BCACP, AAHIVP
Karen Kier, Ph.D., MSc, R.Ph., BCPS, BCACP, CTTS, FASHP, FCCP
Danielle LaPrad, Pharm.D., BCACP
Brian Leonard, Pharm.D.
Jennifer Lockhart, Pharm.D., BCACP
Jeanne Long, R.Ph., BCACP
Matthew Maddox, Pharm.D., BCACP, BCGP, CPH
Marlies Mathis, Pharm.D., BCGP
Amy Mgonja, Pharm.D., BCGP
Alex Mills, Pharm.D., BCACP, AAHIVP
Osariemen Nosa-Idahosa, Pharm.D., BCPS, BCACP, BCGP
Jennifer Overman, Pharm.D., PhC, BCACP
Ha Phan, Pharm.D., CDCES, BCACP
Krystal Riccio, Pharm.D., BCACP, CDCES
Kathleen Romero, Pharm.D., BCACP
Shelly Rutledge, Pharm.D., BCACP, INHC
Michael Schnackenberg, Pharm.D., M.B.A., BCACP
Megan Sizemore, BCACP, BCMTMS, Pharm.D., R.Ph.
Morgan Stewart, Pharm.D., BCACP
Kendra Strum, Pharm.D., BCGP
S. Rochelle Sullivan, Pharm.D., BCACP
Michelle VanGerven, Pharm D, BCACP
Hilary Weismantel, Pharm.D., BCACP
Emily Weissman, Pharm.D., R.Ph., BCGP
Stephanie Whitee, Pharm.D., BCACP
Christine Wu, Pharm.D., BCPS, BCGP
Amanda Zelinski, Pharm.D., BCACP


In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support and the Accreditation Council for Pharmacy Education’s Standards for Commercial Support, ASHP requires that all individuals involved in the development of activity content disclose their relevant financial relationships. A person has a relevant financial relationship if the individual of his or her spouse/partner has a financial relationship (e.g. employee, consultant, research grant recipient, speakers bureau, or stockholder) in any amount occurring the in the last 12 months with a commercial interest whose products or series may be discussed in the educational activity content over which the individual has control. The existence of these relationships is provided for the information of participants and should not be assumed to have an adverse impact on the content.

All faculty and planners for ACCP and ASHP education activities are qualified and selected by ACCP and ASHP required to disclose any relevant financial relationships with commercial interests. ACCP and ASHP identifies and resolves conflicts of interest prior to an individual’s participation in development of content for an educational activity. Anyone who refuses to disclose relevant financial relationships must be disqualified from any involvement with a continuing pharmacy education activity.

All other planners, presenters, reviewers, ACCP and ASHP staff and others with an opportunity to control content report no financial relationships relevant to this activity.

Methods and CE Requirements

Activities consist of audio/video/PDF files, an attestation statement, and activity evaluation. Learners must review all content and complete the attestation statement and course evaluation to receive continuing pharmacy education credit for each activity.

Follow the prompts to claim, view, or print the statement of credit within 60 days after completing the activity.

System Technical Requirements

Learning activities are delivered via your Web browser and Acrobat PDF. For all activities, you should have a basic comfort level using a computer and navigating web sites.

View the minimum technical and system requirements for learning activities.


These activities were developed by ACCP and ASHP.